Thursday, November 21, 2024
Subscribe American Journal of Medicine Free Newsletter
Physical ExambleedingRaccoon Eye Appearance: Amyloidosis

Raccoon Eye Appearance: Amyloidosis

Photograph of the patient's face shows bilateral periorbital ecchymosis (raccoon eye appearance).
Photograph of the patient’s face shows bilateral periorbital ecchymosis (raccoon eye appearance).

To the Editor:

An 82-year-old woman presented to our outpatient clinic with a 6-month history of recurrent internal bleeding near the eyes. The patient had a history of type 2 diabetes mellitus, but had no significant medical history including traumatic injuries. Physical examination revealed bilateral periorbital ecchymosis and large tongue (Figure). Serum protein electrophoresis revealed an M-peak in the gamma fraction, and urine immunofixation electrophoresis was positive for Bence-Jones protein. In addition, amyloid fibrils were detected in biopsy of abdominal subcutaneous fat tissue. On the basis of the clinical and immunohistological findings, we made a diagnosis of amyloid light-chain amyloidosis. Amyloid light-chain amyloidosis is a rare, multisystem disease characterized by the deposition of amyloid in various organs and extracellular tissue, including the kidney, heart, liver, digestive tract, spleen, and autonomic nervous system.1 However, symptoms in the early stage vary widely and include weakness, epigastric discomfort, weight loss, and poor appetite. These symptoms are often vague and nonspecific, and can be confused with other disorders. The gradual amyloid deposition results in damage and affected function in the organs and tissues, and the other symptoms in the most commonly affected organs and tissues include nephrotic-range proteinuria, congestive cardiomyopathy, macroglossia, hematemesis, hematochezia, and autonomic or sensory neuropathy. Untreated amyloidosis has progressive, irreversible consequences and can ultimately result in death. Thus, an early and precise diagnosis of amyloid light-chain amyloidosis is essential in order to prevent further organ damage. Therefore, when the raccoon eye appearance is present, clinicians should consider amyloidosis as a possible differential diagnosis.

To read this article in its entirety please visit our website.

-Hiroki Matsuura, MD, Yoshiaki Anzai, MD, Naoki Kuninaga, MD, Takeshi Maeda, MD

This article originally appeared in the July issue  of The American Journal of Medicine.

Latest Posts

lupus

Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man

A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flue Vaccine

Flu Vaccination to Prevent Cardiovascular Mortality (video)

0
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
varicella zoster

Varicella Zoster Virus-Induced Complete Heart Block

0
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Racial justice in healthcare

Teaching Anti-Racism in the Clinical Environment

0
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
Invisible hand of the market

The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs

0
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
Joseph S. Alpert, MD

New Coronary Heart Disease Risk Factors

0
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiovascular risk from noncardiac activities

Cardiac Risk Related to Noncardiac & Nonsurgical Activities

0
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine. Cardiovascular risk...